Based on these data we decided to conduct a retrospective study in order to investigate the predictive significance of BRCA1 and TXR1–TSP1 mRNA expression in NSCLC patients treated with docetaxel-based doublets. The gene discussed is PRR13; the disease is non-small cell lung carcinoma.